AbbVie (NYSE:ABBV) said it has received FDA approval for the intravenous antibiotic treatment Emblaveo, which was co-developed with Pfizer (NYSE:PFE). The FDA approved Emblaveo, a combination of ...
Antibiotics are a powerful tool in fighting bacterial infections like strep throat, whooping cough or a urinary tract infection. But they can leave the patient with nausea, diarrhea or an upset ...
Bacteriophage MarketThe global bacteriophage market, valued at USD 45.07 million in 2023, is projected to reach USD 68 million by 2033, growing at a CAGR of 4.2% over the forecast period. The ...
Pregnant women with obesity face an increased risk of complications, including the need for a cesarean section, which carries ...
Trends include a shortened duration of therapy coupled with a reduced number of individuals who warrant antibiotic prophylaxis. A re-evaluation of the feasibility and ethical concerns regarding ...
In a recent study, peri- and postmenopausal women with recurrent UTIs saw a 58% lower risk of recurrence with a 1-month course of treatment-strength antibiotics compared to low-dose prophylactic ...
Sodium-cooled fast reactors using metallic-alloy fuel are attracting attention because they are inherently safe and produce more fuel than they use.
Doxycycline postexposure prophylaxis (doxyPEP ... the pace of vaccine development has been slow, and that of new antibiotic development…has been glacial.” Marazzo and her associate wrote.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback